Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Share $0.00001 Par Value
- Shares outstanding
- 51,428,000
- Total 13F shares
- 46,436,015
- Share change
- +1,449,444
- Total reported value
- $512,193,131
- Price per share
- $11.03
- Number of holders
- 134
- Value change
- +$17,041,767
- Number of buys
- 76
- Number of sells
- 52
Report period
Q2 2025
Institutions
134
Top holders
10
TBPH full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Madison Avenue Partners, LP |
13F
|
Company |
18%
|
9,511,150
|
$84,934,570 | — | 31 Mar 2025 | |
| Weiss Asset Management LP |
3/4/5
13F
|
10%+ Owner · Company |
14%
from 13F
|
7,457,060
|
$76,733,147 | — | 19 Sep 2022 | |
| Eli Samaha |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
9,511,150
|
$74,186,970 | — | 07 Aug 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
9.3%
|
4,757,403
|
$42,483,609 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
6.5%
|
3,235,696
|
$31,548,036 | $0 | 31 Mar 2025 | |
| Irenic Capital Management LP |
13F
|
Company |
5.4%
|
2,760,948
|
$24,655,266 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
2,080,463
|
$18,578,535 | — | 31 Mar 2025 | |
| Park West Asset Management LLC |
13F
|
Company |
3.5%
|
1,804,244
|
$16,111,899 | — | 31 Mar 2025 | |
| Oasis Management Co Ltd. |
13F
|
Company |
2.2%
|
1,118,935
|
$9,992,089 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,066,775
|
$9,526,301 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13F
|
Company |
1.9%
|
1,000,000
|
$8,930,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.8%
|
920,302
|
$8,218,297 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
890,567
|
$7,954,699 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
643,838
|
$5,750,764 | — | 31 Mar 2025 | |
| Frank Pasqualone |
3/4/5
|
SVP, CHIEF BUSINESS OFFICER |
—
class O/S missing
|
429,783
|
$4,422,467 | — | 19 Nov 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.9%
|
463,228
|
$4,136,626 | — | 31 Mar 2025 | |
| Andrew A. Hindman |
3/4/5
|
SVP, CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
384,714
|
$3,958,707 | — | 18 Nov 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.85%
|
438,709
|
$3,917,671 | — | 31 Mar 2025 | |
| Kenneth R. Pitzer |
3/4/5
|
SVP, PROD STRAT & COMM PLNG |
—
class O/S missing
|
380,123
|
$3,911,466 | — | 18 Feb 2022 | |
| UBS Group AG |
13F
|
Company |
0.81%
|
417,621
|
$3,729,355 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.75%
|
384,987
|
$3,437,934 | — | 31 Mar 2025 | |
| Philip D. Worboys |
3/4/5
|
SVP, RESEARCH & TRANSL SCIENCE |
—
class O/S missing
|
330,752
|
$3,403,438 | — | 19 Nov 2021 | |
| Nuveen, LLC |
13F
|
Company |
0.73%
|
374,952
|
$3,348,321 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
349,417
|
$3,120,293 | — | 31 Mar 2025 | |
| Bradford J. Shafer |
3/4/5
|
EVP, Gen. Counsel, Secretary |
—
class O/S missing
|
277,831
|
$2,858,881 | — | 20 Aug 2021 | |
| Richard A. Graham |
3/4/5
|
SVP, RESEARCH & DEVELOPMENT |
—
class O/S missing
|
314,915
|
$2,809,042 | — | 20 Feb 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.58%
|
296,172
|
$2,644,816 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
291,534
|
$2,603,399 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
287,716
|
$2,569,304 | — | 31 Mar 2025 | |
| Vijay Sabesan |
3/4/5
|
SVP, TECHNICAL OPERATIONS |
—
class O/S missing
|
235,524
|
$2,423,542 | — | 19 Nov 2021 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
262,896
|
$2,347,661 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.43%
|
221,469
|
$1,977,718 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.41%
|
210,536
|
$1,880,086 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.41%
|
208,783
|
$1,864,000 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.38%
|
196,573
|
$1,755,397 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.35%
|
182,350
|
$1,628,000 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
174,594
|
$1,554,000 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.32%
|
165,424
|
$1,477,236 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.31%
|
161,797
|
$1,444,847 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
156,817
|
$1,400,376 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.3%
|
155,429
|
$1,387,981 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.27%
|
140,884
|
$1,258,094 | — | 31 Mar 2025 | |
| Burton G. Malkiel |
3/4/5
|
Director |
—
mixed-class rows
|
137,633
mixed-class rows
|
$1,189,411 | — | 02 May 2023 | |
| Ann Brady |
3/4/5
|
PRESIDENT, TBIL |
—
class O/S missing
|
110,319
|
$1,135,183 | — | 18 Feb 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
117,499
|
$1,049,265 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.22%
|
113,939
|
$1,017,475 | — | 31 Mar 2025 | |
| Dean J. Mitchell |
3/4/5
|
Director |
—
mixed-class rows
|
115,462
mixed-class rows
|
$889,239 | — | 19 May 2025 | |
| William D. Young |
3/4/5
|
Director |
—
mixed-class rows
|
106,010
mixed-class rows
|
$802,723 | — | 26 Apr 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.17%
|
88,577
|
$790,993 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.17%
|
85,707
|
$765,364 | — | 31 Mar 2025 |
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q2 2025
As of 30 Jun 2025,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,436,015 shares.
The largest 10 holders included
Madison Avenue Partners, LP, Weiss Asset Management LP, Newtyn Management, LLC, BlackRock, Inc., Irenic Capital Management LP, VANGUARD GROUP INC, Park West Asset Management LLC, Oasis Management Co Ltd., STATE STREET CORP, and D. E. Shaw & Co., Inc..
This page lists
134
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
130
Q2 2025 holders
134
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.